Skip to main content

Find Clinical Trials

Home
Conditions
Cholangiocarcinoma

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

269 public trials 77 recruiting studies

Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Not Yet Recruiting

Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar Cholangiocarcinoma

NCT06434493

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma

NCT06530823

Conditions: Adenocarcinoma, Biliary Tract Carcinoma, Carcinoma, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin

NCT06490198

Conditions: Adenocarcinoma, Carcinoma, Chemotherapy Effect, +5 more
Locations: Chang Gung Memorial Hospital Linkou Branch Taoyuan, Taiwan

Chang-Gung Memorial Hospital, Linkou Branch Taoyuan, Taiwan

View Trial Details

Not Yet Recruiting

Digital Single-operator Cholangioscopy and Intraductal Ultrasound for Nonicteric Biliary Strictures

NCT06369896

Conditions: Adenocarcinoma, Biliary Stricture, Carcinoma, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma

NCT06175845

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +20 more
Locations: University Medical Center Hamburg-Eppendorf Hamburg, Germany

View Trial Details

Completed

Safety and Efficacy of EUS-guided Gallbladder Drainage Under Endoscopist-directed Conscious Sedation

NCT07704021

Conditions: Adenocarcinoma, Biliary Tract Diseases, Carcinoma, +15 more
Locations: Ospedale Guglielmo da Saliceto di Piacenza Piacenza, PC, Italy

View Trial Details

Completed

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

NCT05185947

Conditions: Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +43 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Tislelizumab and Regorafenib as First-Line Therapy for Advanced Cholangiocarcinoma

NCT07619937

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations: The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China

View Trial Details

Completed

Prospective Evaluation of Biliary Tissue Sampling With ERCP

NCT04572711

Conditions: Adenocarcinoma, Biliary Stricture, Biliary Tract Diseases, +7 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

NCT05461430

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +139 more
Locations: xCures Oakland, California, United States

View Trial Details